Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

© 2013 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of azapirones on panic disorder in adults, specifically: to determine the efficacy of azapirones in alleviating symptoms of panic disorder, with or without agoraphobia, in comparison with placebo; to review the acceptability of azapirones in panic disorder, with or without agoraphobia, in comparison with placebo; and to investigate the adverse effects of azapirones in panic disorder with or without agoraphobia, including general prevalence of adverse effects, compared with placebo.

Original publication

DOI

10.1002/14651858.CD010828

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

26/11/2013

Volume

2013